RCUS Arcus Biosciences, Inc.

Fundamentals / CIK 0001724521 / USD

Arcus Biosciences, Inc. reported $100.0M in revenue and a net loss of $453.0M for the trailing twelve months ended September 30, 2026 (down 65.4% year over year), with a -475.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RCUS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$414.8M$207.4M$0-$362.6MFY 2016 Net Income: -$17.97M2016FY 2017 Revenue: $1.41MFY 2017 Net Income: -$53.08M2017FY 2018 Revenue: $8.35MFY 2018 Net Income: -$49.59M2018FY 2019 Revenue: $15.00MFY 2019 Net Income: -$84.71M2019FY 2020 Revenue: $78.00MFY 2020 Net Income: -$123.0M2020FY 2021 Revenue: $383.0MFY 2021 Net Income: $53.00M2021FY 2022 Revenue: $112.0MFY 2022 Net Income: -$267.0M2022FY 2023 Revenue: $117.0MFY 2023 Net Income: -$307.0M2023FY 2024 Revenue: $258.0MFY 2024 Net Income: -$283.0M2024FY 2025 Revenue: $247.0MFY 2025 Net Income: -$353.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $247.0M $258.0M $117.0M $112.0M $383.0M $78.00M $15.00M $8.35M $1.41M --
Research & Development $523.0M $448.0M $340.0M $288.0M $257.0M $159.0M $78.48M $49.65M $47.22M $14.25M
Total Operating Expenses $633.0M $588.0M $457.0M $392.0M $329.0M $202.0M $103.7M $63.21M $54.85M $18.18M
Operating Income -$386.0M -$330.0M -$340.0M -$280.0M $54.00M -$124.0M -$88.71M -$54.86M -$53.44M -$18.18M
EBITDA -$376.0M -$320.0M -$332.0M -$274.0M $58.00M -$121.0M -$85.13M -$51.20M -$50.83M -$16.87M
Interest Expense $8.00M $4.00M $2.00M $2.00M -- -- -- -- -- --
Income Before Tax -$353.0M -$282.0M -$301.0M -$266.0M $55.00M -$123.0M -$84.71M -- -- --
Income Tax Expense $0 $1.00M $6.00M $1.00M $2.00M -- -- -- -- --
Net Income -$353.0M -$283.0M -$307.0M -$267.0M $53.00M -$123.0M -$84.71M -$49.59M -$53.08M -$17.97M
Basic EPS -$3.29 -$3.14 -$4.15 -$3.71 $0.76 -$2.24 -$1.93 -$1.43 -$29.03 -$20.80
Diluted EPS -$3.29 -$3.14 -$4.15 -$3.71 $0.71 -$2.24 -$1.93 -$1.43 -$29.03 -$20.80
Basic Shares Outstanding 107.4M 90.1M 74.0M 72.0M 69.3M 54.8M 43.8M 36.4M 3.9M 3.4M
Diluted Shares Outstanding 107.4M 90.1M 74.0M 72.0M 74.0M 54.8M 43.8M 34.6M 1.8M 864.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $9.00M $41.00M $17.00M $33.00M $26.00M $160.0M $28.00M $26.00M
Research & Development $117.0M $113.0M $122.0M $121.0M $141.0M $139.0M $122.0M $101.0M
Total Operating Expenses $140.0M $137.0M $151.0M $147.0M $168.0M $168.0M $150.0M $129.0M
Operating Income -$131.0M -$96.00M -$134.0M -$114.0M -$142.0M -$8.00M -$122.0M -$103.0M
EBITDA -$129.0M -$93.00M -$132.0M -$111.0M -$140.0M -$6.00M -$119.0M -$100.0M
Interest Expense $3.00M $3.00M $3.00M $2.00M $3.00M $2.00M $1.00M $2.00M
Income Before Tax -$128.0M -$91.00M -$128.0M -$106.0M -$135.0M $0 -$112.0M -$93.00M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $1.00M
Net Income -$128.0M -$91.00M -$128.0M -$106.0M -$135.0M $0 -$112.0M -$94.00M
Basic EPS -$1.00 -$0.72 -$1.02 -- -$1.27 $0.00 -$1.14 --
Diluted EPS -$1.00 -$0.72 -$1.02 -- -$1.27 $0.00 -$1.14 --
Basic Shares Outstanding 127.4M 126.1M 125.4M -- 106.5M 106.1M 98.4M --
Diluted Shares Outstanding 127.4M 126.1M 125.4M -- 106.5M 106.5M 98.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $222.0M $150.0M $127.0M $206.0M $148.0M $173.4M $57.94M $71.06M $98.43M
Short-Term Investments $759.0M $828.0M $632.0M $803.0M $351.0M $555.2M -- -- --
Cash & Short-Term Investments $981.0M $978.0M $759.0M $1.01B $499.0M $728.6M $57.94M $71.06M $98.43M
Total Current Assets $1.01B $1.02B $831.0M $1.07B $1.26B $735.8M $192.7M $258.9M $176.9M
Property, Plant & Equipment, Net $40.00M $47.00M $51.00M $35.00M $32.00M $10.81M $9.33M $11.11M $11.23M
Long-Term Investments $29.00M $14.00M $107.0M $129.0M $182.0M $6.44M -- -- --
Other Non-Current Assets $63.00M $73.00M $106.0M $114.0M $116.0M $6.25M $872K $284K $1.50M
Total Non-Current Assets $132.0M $134.0M $264.0M $278.0M $330.0M $36.48M $10.40M $15.98M $13.62M
Total Assets $1.14B $1.15B $1.09B $1.34B $1.59B $772.3M $203.1M $274.9M $190.5M
Accounts Payable $42.00M $18.00M $17.00M $20.00M $10.00M $15.68M $4.70M $3.10M $3.82M
Deferred Revenue (Current) $35.00M $85.00M $91.00M $97.00M $102.0M $74.57M $7.00M $6.25M $5.00M
Other Current Liabilities $154.0M $123.0M $76.00M $76.00M $54.00M $3.57M $1.48M $1.56M $769K
Total Current Liabilities $231.0M $226.0M $184.0M $193.0M $166.0M $121.7M $22.71M $16.93M $12.73M
Long-Term Debt $99.00M $48.00M $0 -- -- -- -- -- --
Deferred Revenue (Non-Current) $43.00M $234.0M $307.0M $355.0M $462.0M $132.5M $12.02M $16.98M $18.59M
Other Non-Current Liabilities $135.0M $157.0M $142.0M $140.0M $122.0M $543K $806K $1.79M $565K
Total Non-Current Liabilities $277.0M $439.0M $449.0M $495.0M $584.4M $148.3M $16.56M $23.05M $23.89M
Total Liabilities $508.0M $665.0M $633.0M $688.0M $750.4M $270.0M $39.27M $39.98M $36.62M
Total Debt (incl. Leases) $198.0M $159.0M $121.0M $126.0M $113.6M $18.11M -- -- --
Common Stock $2.12B $1.62B $1.31B $1.21B $1.12B $6.0K $4.0K $4.0K --
Retained Earnings -$1.49B -$1.13B -$849.0M -$542.0M -$275.0M -$328.2M -$205.3M -$122.8M -$73.23M
Accumulated Other Comp. Income $0 -- $0 -$7.00M -$1.00M $44K $64K -$107K -$42K
Total Stockholders' Equity $631.0M $485.0M $462.0M $657.0M $842.0M $502.0M $164.0M $234.9M -$72.33M
Total Equity $631.0M $485.0M $462.0M $657.0M $842.0M $502.0M $164.0M $234.9M -$72.33M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $151.0M $150.0M $201.0M $222.0M $238.0M $248.0M $192.0M $150.0M
Short-Term Investments $479.0M $552.0M $621.0M $759.0M $593.0M $663.0M $805.0M $828.0M
Cash & Short-Term Investments $630.0M $702.0M $822.0M $981.0M $831.0M $911.0M $997.0M $978.0M
Total Current Assets $664.0M $756.0M $844.0M $1.01B $857.0M $946.0M $1.03B $1.02B
Property, Plant & Equipment, Net $33.00M $36.00M $38.00M $40.00M $42.00M $44.00M $46.00M $47.00M
Long-Term Investments $64.00M $73.00M $54.00M $29.00M $10.00M $16.00M $8.00M $14.00M
Other Non-Current Assets $57.00M $59.00M $61.00M $63.00M $65.00M $69.00M $71.00M $73.00M
Total Non-Current Assets $154.0M $168.0M $153.0M $132.0M $117.0M $129.0M $125.0M $134.0M
Total Assets $818.0M $924.0M $997.0M $1.14B $974.0M $1.07B $1.16B $1.15B
Accounts Payable $44.00M $34.00M $39.00M $42.00M $42.00M $29.00M $22.00M $18.00M
Deferred Revenue (Current) $14.00M $19.00M $34.00M $35.00M $52.00M $71.00M $72.00M $85.00M
Other Current Liabilities $141.0M $145.0M $136.0M $154.0M $141.0M $110.0M $98.00M $123.0M
Total Current Liabilities $199.0M $198.0M $209.0M $231.0M $235.0M $210.0M $192.0M $226.0M
Long-Term Debt $102.0M $101.0M $100.0M $99.00M $98.00M $97.00M $48.00M $48.00M
Deferred Revenue (Non-Current) $34.00M $37.00M $45.00M $43.00M $53.00M $60.00M $219.0M $234.0M
Other Non-Current Liabilities $125.0M $124.0M $119.0M $135.0M $152.0M $159.0M $166.0M $157.0M
Total Non-Current Liabilities $261.0M $262.0M $264.0M $277.0M $303.0M $316.0M $433.0M $439.0M
Total Liabilities $460.0M $460.0M $473.0M $508.0M $538.0M $526.0M $625.0M $665.0M
Total Debt (incl. Leases) $116.0M $114.0M $113.0M $198.0M $111.0M $109.0M $60.00M $159.0M
Common Stock $2.19B $2.17B $2.14B $2.12B $1.81B $1.79B $1.77B $1.62B
Retained Earnings -$1.83B -$1.70B -$1.61B -$1.49B -$1.38B -$1.24B -$1.24B -$1.13B
Accumulated Other Comp. Income -$2.00M -$1.00M -$1.00M $0 -- -- -- --
Total Stockholders' Equity $358.0M $464.0M $524.0M $631.0M $436.0M $549.0M $531.0M $485.0M
Total Equity $358.0M $464.0M $524.0M $631.0M $436.0M $549.0M $531.0M $485.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$353.0M -$283.0M -$307.0M -$267.0M $53.00M -$123.0M -$84.71M -$49.59M -$53.08M -$17.97M
Depreciation & Amortization $10.00M $10.00M $8.00M $6.00M $4.00M $3.00M $3.58M $3.66M $2.61M $1.31M
Stock-Based Compensation $60.00M $76.00M $73.00M $65.00M $55.00M $22.00M $8.98M $3.87M $495K $90K
Change in Payables $24.00M $3.00M -$1.00M $8.00M -$5.00M $9.00M $1.73M -$69K -$267K $3.57M
Operating Cash Flow -$482.0M -$170.0M -$306.0M $438.0M -$256.0M $111.0M -$73.46M -$43.00M -$25.06M -$12.94M
Capital Expenditure -$2.00M -$6.00M -$24.00M -$6.00M -$26.00M -$3.00M -$1.93M -$3.74M -$5.51M -$4.10M
Free Cash Flow -$484.0M -$176.0M -$330.0M $432.0M -$282.0M $108.0M -$75.39M -$46.74M -$30.57M -$17.04M
Purchases of Investments -$1.08B -$1.04B -$788.0M -$1.24B -$718.9M -$739.7M -$247.8M -$261.6M -$96.83M -$33.76M
Sales & Maturities of Investments -- -- -- -- $690.1M $307.3M $308.9M $151.9M $53.27M $0
Investing Cash Flow $66.00M -$84.00M $194.0M -$413.0M -$4.00M -$434.0M $59.21M -$113.4M -$49.07M -$38.86M
Common Stock Issued $429.0M $228.0M $25.00M $0 $220.0M $434.0M $1.22M $4.10M -- --
Share Repurchases -- -- -- -- -- -- -$94K $0 -- --
Financing Cash Flow $488.0M $277.0M $33.00M $33.00M $237.0M $439.0M $1.12M $129.1M $107.4M $70.10M
Net Change in Cash $72.00M $23.00M -$79.00M $58.00M -$23.00M $116.0M -$13.13M -$27.36M $33.27M $18.30M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$128.0M -$91.00M -$128.0M -$106.0M -$135.0M $0 -$112.0M -$94.00M
Depreciation & Amortization $2.00M $3.00M $2.00M $3.00M $2.00M $2.00M $3.00M $3.00M
Stock-Based Compensation $16.00M $15.00M $19.00M $15.00M $14.00M $15.00M $16.00M $17.00M
Change in Payables $10.00M -$5.00M -$3.00M $0 $13.00M $8.00M $3.00M $5.00M
Operating Cash Flow -$88.00M -$119.0M -$138.0M -$120.0M -$97.00M -$133.0M -$132.0M -$100.0M
Capital Expenditure $0 $0 $0 -$1.00M $0 $0 -$1.00M -$1.00M
Free Cash Flow -$88.00M -$119.0M -$138.0M -$121.0M -$97.00M -$133.0M -$133.0M -$101.0M
Purchases of Investments -$131.0M -$182.0M -$150.0M -$397.0M -$165.0M -$161.0M -$353.0M -$172.0M
Investing Cash Flow $82.00M $52.00M $114.0M -$182.0M $79.00M $137.0M $32.00M $51.00M
Common Stock Issued $0 $0 $0 $279.0M $8.00M $0 $142.0M $0
Financing Cash Flow $7.00M $16.00M $3.00M $286.0M $8.00M $52.00M $142.0M -$2.00M
Net Change in Cash $1.00M -$51.00M -$21.00M -$16.00M -$10.00M $56.00M $42.00M -$51.00M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -156.3% -127.9% -290.6% -250.0% 14.1% -159.0% -591.4% -656.8% -3782.1% --
Net Profit Margin -142.9% -109.7% -262.4% -238.4% 13.8% -157.7% -564.7% -593.7% -3756.7% --
Return on Equity (ROE) -55.9% -58.4% -66.5% -40.6% 6.3% -24.5% -51.7% -21.1% -- --
Return on Assets (ROA) -31.0% -24.6% -28.0% -19.9% 3.3% -15.9% -41.7% -18.0% -27.9% --
Current Ratio 4.36x 4.50x 4.52x 5.53x 7.60x 6.05x 8.49x 15.29x 13.90x --
Quick Ratio 4.25x 4.33x 4.12x 5.23x 3.01x 5.99x 2.55x 4.20x 7.73x --
Debt to Equity 0.31x 0.33x 0.26x 0.19x 0.13x 0.04x -- -- -- --
Revenue Growth (YoY) -4.3% +120.5% +4.5% -70.8% +391.0% +420.0% +79.6% +491.2% -- --
Operating Income Growth (YoY) -- -- -- -618.5% -- -- -- -- -- --
Net Income Growth (YoY) -- -- -- -603.8% -- -- -- -- -- --
EPS Growth (YoY) -- -- -- -588.2% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -169.9% -- -330.6% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -176.4% -- -361.1% -- -- -- -- --
5Y Revenue / Share Growth +61.6% +736.6% +588.2% +327.8% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -475.0% -415.4% -168.6% -156.3% -156.2% -129.0% -309.2% -127.9%
Net Profit Margin -453.0% -393.2% -156.4% -142.9% -142.1% -113.7% -277.3% -109.7%
Return on Equity (ROE) -126.5% -99.1% -70.4% -55.9% -78.2% -54.3% -73.6% -58.4%
Return on Assets (ROA) -55.4% -49.8% -37.0% -31.0% -35.0% -27.7% -33.8% -24.6%
Current Ratio 3.34x 3.82x 4.04x 4.36x 3.65x 4.50x 5.37x 4.50x
Quick Ratio 3.17x 3.55x 3.93x 4.25x 3.54x 4.34x 5.19x 4.33x
Debt to Equity 0.32x 0.25x 0.22x 0.31x 0.25x 0.20x 0.11x 0.33x
Revenue Growth (YoY) -65.4% -74.4% -39.3% +26.9% -45.8% +310.3% -80.7% --
Operating Cash Flow Growth (YoY) -- -- -- -- -473.1% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -488.0% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001724521) · from December 31, 2016 Data through September 30, 2026 · synced Nov 20, 2026, 05:21 UTC · Open in terminal